{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T05:13:33Z","timestamp":1784265213818,"version":"3.55.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,11,15]],"date-time":"2023-11-15T00:00:00Z","timestamp":1700006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,11,15]],"date-time":"2023-11-15T00:00:00Z","timestamp":1700006400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Antimicrobial resistance is one of the common global public health problems. The emergence of antimicrobial resistance is multifactorial, and tackling its development is challenging. Consequently, infections caused by resistant bacteria are unresponsive to conventional drugs, resulting in prolonged and severe illnesses, higher mortality rates, and considerable healthcare costs. Therefore, understanding the antimicrobial resistance profiles of bacterial pathogens is essential to optimize treatments and reduce the risks associated with infections. This study aimed to determine the antimicrobial resistance patterns of bacterial isolates from different clinical specimens at the Ethiopian Public Health Institute (EPHI).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Materials and methods<\/jats:title>\n                <jats:p>The retrospective cross-sectional study was conducted on the bacterial culture and antibiotic susceptibility reports of different clinical specimens referred to the Bacteriology Laboratory of EPHI from September 2015 to August 2019. Standard bacteriological techniques were used for the isolation and identification of the bacteria. Data were extracted from 840 patients\u2019 records, which included the type of clinical sample cultured, the name of the bacteria, the representations of the antibiotics used for susceptibility testing, and the susceptibility results. Descriptive statistics were used to describe the bacterial isolates and the antimicrobial resistance profiles.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Eight types of clinical specimens were analyzed for bacterial isolates and urine specimens were the most analyzed. Ten different genera of bacteria were identified by culture. Almost all the isolates were gram-negative bacteria, while only one species of gram-positive (<jats:italic>Staphylococcus aureus<\/jats:italic>) was reported. Antibiotic sensitivity patterns were tested on 840 culture isolates. <jats:italic>Escherichia coli<\/jats:italic> strains revealed more than 57% resistance to seventeen antibiotics. <jats:italic>Klebsiella pneumoniae<\/jats:italic> showed nearly 70% or greater resistance rates for 17 of the antibiotics used. The overall detected multidrug resistance (MDR) was 64.29%. The highest MDR was reported in <jats:italic>Acinetobacter<\/jats:italic> strains (84%) followed by <jats:italic>K. pneumoniae<\/jats:italic> (80%).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>The multidrug resistance rates found in this study were alarming. Strengthening antimicrobial resistance surveillance at the national level is mandatory, and antimicrobial sensitivity testing should be accessible at local diagnostic centers.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12879-023-08803-x","type":"journal-article","created":{"date-parts":[[2023,11,15]],"date-time":"2023-11-15T09:02:15Z","timestamp":1700038935000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Antimicrobial resistance profiles of bacterial isolates from clinical specimens referred to Ethiopian Public Health Institute: analysis of 5-year data"],"prefix":"10.1186","volume":"23","author":[{"given":"Belay Tafa","family":"Regassa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wagi","family":"Tosisa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Eshetu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Degefu","family":"Beyene","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abera","family":"Abdeta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abebe Aseffa","family":"Negeri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dejenie Shiferaw","family":"Teklu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geremew","family":"Tasew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Begna","family":"Tulu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tadesse","family":"Awoke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,11,15]]},"reference":[{"key":"8803_CR1","unstructured":"WHO. Antimicrobial Resistance. 17 November 2021.\u00a0Available at: https:\/\/wwwwhoint\/news-room\/fact-sheets\/detail\/antimicrobial-resistance. Accessed on 14 Oct 2022."},{"issue":"2","key":"8803_CR2","first-page":"114","volume":"2","author":"BI Coculescu","year":"2009","unstructured":"Coculescu BI. Antimicrobial resistance induced by genetic changes. J Med Life. 2009;2(2):114.","journal-title":"J Med Life"},{"key":"8803_CR3","unstructured":"WHO. Antibiotic resistance. 31 July 2020.\u00a0Available at: https:\/\/wwwwhoint\/news-room\/fact-sheets\/detail\/antibiotic-resistance. Accessed on 14 Oct 2022."},{"issue":"3","key":"8803_CR4","doi-asserted-by":"publisher","first-page":"86","DOI":"10.3390\/antibiotics8030086","volume":"8","author":"P Collignon","year":"2019","unstructured":"Collignon P, Beggs JJJA. Socioeconomic enablers for contagion: factors impelling the antimicrobial resistance epidemic. Antibiotics. 2019;8(3):86.","journal-title":"Antibiotics"},{"issue":"2","key":"8803_CR5","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.mjafi.2014.04.011","volume":"71","author":"A Jindal","year":"2015","unstructured":"Jindal A, Pandya K, Khan ID. Antimicrobial resistance: a public health challenge. Med J Armed Forces India. 2015;71(2):178\u201381.","journal-title":"Med J Armed Forces India."},{"key":"8803_CR6","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1179\/2047773215Y.0000000030","volume":"109","author":"F Prestinaci","year":"2015","unstructured":"Prestinaci F, Pezzotti P, Pantosti A. Antimicrobial resistance: a global multifaceted phenomenon. Pathog Glob Health. 2015;109:309\u201318.","journal-title":"Pathog Glob Health"},{"key":"8803_CR7","unstructured":"WHO. WHO global strategy for containment of antimicrobial resistance. World Health Organization; 2001.\u00a0Available at:\u00a0https:\/\/iris.who.int\/bitstream\/handle\/10665\/66860\/WHO_CDS_CSR_DRS_2001.2.pdf."},{"key":"8803_CR8","unstructured":"WHO. The evolving threat of antimicrobial resistance: options for action.\u00a0Geneva: World Health Organization; 2012.\u00a0Available at: https:\/\/iris.who.int\/bitstream\/handle\/10665\/44812\/?sequence=1."},{"key":"8803_CR9","unstructured":"WHO. Antimicrobial resistance: global report on surveillance.\u00a0Geneva: World Health Organization; 2014.\u00a0Available at: https:\/\/iris.who.int\/bitstream\/handle\/10665\/112642\/?sequence=1."},{"key":"8803_CR10","doi-asserted-by":"publisher","first-page":"539","DOI":"10.3389\/fmicb.2019.00539","volume":"10","author":"MS Mulani","year":"2019","unstructured":"Mulani MS, Kamble EE, Kumkar SN, Tawre MS, Pardesi KR. Emerging strategies to combat ESKAPE pathogens in the era of antimicrobial resistance: a review. Front Microbiol. 2019;10:539.","journal-title":"Front Microbiol."},{"issue":"3","key":"8803_CR11","doi-asserted-by":"publisher","first-page":"e00181","DOI":"10.1128\/CMR.00181-19","volume":"33","author":"DM De Oliveira","year":"2020","unstructured":"De Oliveira DM, Forde BM, Kidd TJ, Harris PN, Schembri MA, Beatson SA, et al. Antimicrobial resistance in ESKAPE pathogens. Clin Microbiol Rev. 2020;33(3):e00181-e219.","journal-title":"Clin Microbiol Rev"},{"issue":"1","key":"8803_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/2050-6511-15-26","volume":"15","author":"B Abera","year":"2014","unstructured":"Abera B, Kibret M, Mulu WJ. Knowledge and beliefs on antimicrobial resistance among physicians and nurses in hospitals in Amhara Region Ethiopia. BMC Pharmacol Toxicol. 2014;15(1):1\u20137.","journal-title":"BMC Pharmacol Toxicol."},{"issue":"1","key":"8803_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13104-019-4604-6","volume":"12","author":"M Abebe","year":"2019","unstructured":"Abebe M, Tadesse S, Meseret G, Derbie AJ. Type of bacterial isolates and antimicrobial resistance profile from different clinical samples at a Referral Hospital, Northwest Ethiopia: five years data analysis. BMC Res Notes. 2019;12(1):1\u20136.","journal-title":"BMC Res Notes."},{"issue":"12","key":"8803_CR14","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1080\/17441692.2018.1449230","volume":"13","author":"MP Joshi","year":"2018","unstructured":"Joshi MP, Chintu C, Mpundu M, Kibuule D, Hazemba O, Andualem T, et al. Multidisciplinary and multisectoral coalitions as catalysts for action against antimicrobial resistance: implementation experiences at national and regional levels. Glob Public Health. 2018;13(12):1781\u201395.","journal-title":"Glob Public Health"},{"key":"8803_CR15","unstructured":"Monica C. District laboratory practice in tropical countries.\u00a0United\u00a0Kingdom: Cambridge University Press; 2006."},{"key":"8803_CR16","unstructured":"Wayne P. Performance Standards for Antimicrobial Susceptibility Testing. USA: 30th CLSI supplement M100. CLSI; 2020."},{"key":"8803_CR17","doi-asserted-by":"crossref","unstructured":"Mnyambwa NP, Mahende C, Wilfred A, Sandi E, Mgina N, Lubinza C, et al. Antibiotic susceptibility patterns of bacterial isolates from routine clinical specimens from Referral Hospitals in Tanzania: a prospective hospital-based observational study. Infection and drug resistance. 2021;14:869\u201378.","DOI":"10.2147\/IDR.S294575"},{"issue":"4","key":"8803_CR18","first-page":"363","volume":"45","author":"S Gebre-Sealsssie","year":"2007","unstructured":"Gebre-Sealsssie S. Antimicrobial resistance patterns of clinical bacterial isolates in southwestern Ethiopia. Ethiop Med J. 2007;45(4):363\u201370.","journal-title":"Ethiop Med J"},{"issue":"3","key":"8803_CR19","first-page":"635","volume":"31","author":"S Abosse","year":"2021","unstructured":"Abosse S, Genet C, Derbie A. Antimicrobial Resistance Profile of Bacterial Isolates Identified from Surgical Site Infections at a Referral Hospital. Northwest Ethiopia Ethiop J Health Sci. 2021;31(3):635\u201344.","journal-title":"Northwest Ethiopia Ethiop J Health Sci"},{"key":"8803_CR20","volume-title":"Prevalence of pathogens and their antimicrobial susceptibility in catheter associated urinary tract infection","author":"M Koshariya","year":"2015","unstructured":"Koshariya M, Songra M, Namdeo R, Chaudhary A, Agarwal S, Rai A. Prevalence of pathogens and their antimicrobial susceptibility in catheter associated urinary tract infection. 2015."},{"key":"8803_CR21","first-page":"5070742","volume":"2018","author":"F Gashe","year":"2018","unstructured":"Gashe F, Mulisa E, Mekonnen M, Zeleke G. Antimicrobial resistance profile of different clinical isolates against third-generation cephalosporins. J Pharm (Cairo). 2018;2018:5070742.","journal-title":"J Pharm (Cairo)"},{"key":"8803_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12879-019-4210-1","volume":"19","author":"T Alemayehu","year":"2019","unstructured":"Alemayehu T, Ali M, Mitiku E, Hailemariam M. The burden of antimicrobial resistance at tertiary care hospital, southern Ethiopia: a three years\u2019 retrospective study. BMC Infect Dis. 2019;19:1\u20138.","journal-title":"BMC Infect Dis"},{"key":"8803_CR23","doi-asserted-by":"crossref","unstructured":"Oumer Y, Regasa Dadi B, Seid M, Biresaw G, Manilal A. Catheter-associated urinary tract infection: Incidence, associated factors and drug resistance patterns of bacterial isolates in southern ethiopia. Infect Drug Resist. 2021:14:2883\u201394.","DOI":"10.2147\/IDR.S311229"},{"key":"8803_CR24","doi-asserted-by":"publisher","first-page":"5729568","DOI":"10.1155\/2019\/5729568","volume":"2019","author":"N Awoke","year":"2019","unstructured":"Awoke N, Kassa T, Teshager L. Magnitude of biofilm formation and antimicrobial resistance pattern of bacteria isolated from urinary catheterized inpatients of Jimma university medical center Southwest Ethiopia. Int J Microbiol. 2019;2019:5729568.","journal-title":"Int J Microbiol."},{"key":"8803_CR25","doi-asserted-by":"crossref","unstructured":"Saleh AM, Al-Shamahy HA, Al-Hrazi RMA, Jaadan BM, AL-Magrami RTF, Al-Sharani AA. Biofilm formation and antibiotic susceptibility of uropathogens in patients with catheter associated urinary tract infections in ibb City-Yemen. Universal J Pharm Res. 2019;4(6):1\u20137.","DOI":"10.22270\/ujpr.v4i6.329"},{"issue":"7","key":"8803_CR26","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.3390\/diagnostics12071695","volume":"12","author":"M Saleem","year":"2022","unstructured":"Saleem M, Syed Khaja AS, Hossain A, Alenazi F, Said KB, Moursi SA, et al. Catheter-associated urinary tract infection in intensive care unit patients at a tertiary care hospital, Hail, Kingdom of Saudi Arabia. Diagnostics. 2022;12(7):1695.","journal-title":"Diagnostics"},{"key":"8803_CR27","doi-asserted-by":"publisher","first-page":"3196","DOI":"10.18203\/2320-1770.ijrcog20203295","volume":"9","author":"A Singh","year":"2020","unstructured":"Singh A, Kujur A, Lakshmi M, Daharwal A. The study of antibiotic-sensitivity and resistance pattern of bacteria causing catheter associated urinary tract infection. Int J Reprod Contracept Obstet Gynecol. 2020;9:3196.","journal-title":"Int J Reprod Contracept Obstet Gynecol"},{"key":"8803_CR28","unstructured":"Divyashanthi C, Adithiyakumar S, Bharathi N. Study of prevalence and antimicrobial susceptibility pattern of bacterial isolates in a tertiary care hospital. International Journal of Pharmacy and Pharmaceutical Sciences. 2015;7(1):185\u201390."},{"issue":"1","key":"8803_CR29","doi-asserted-by":"publisher","first-page":"19710","DOI":"10.1038\/s41598-021-99272-2","volume":"11","author":"M Hailemariam","year":"2021","unstructured":"Hailemariam M, Alemayehu T, Tadesse B, Nigussie N, Agegnehu A, Habtemariam T, et al. Major bacterial isolate and antibiotic resistance from routine clinical samples in Southern Ethiopia. Sci Rep. 2021;11(1):19710.","journal-title":"Sci Rep"},{"issue":"1","key":"8803_CR30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12941-016-0177-6","volume":"16","author":"R-J Ten Hove","year":"2017","unstructured":"Ten Hove R-J, Tesfaye M, Ten Hove WF, Nigussie M. Profiling of antibiotic resistance of bacterial species recovered from routine clinical isolates in Ethiopia. Ann Clin Microbiol Antimicrob. 2017;16(1):1\u20138.","journal-title":"Ann Clin Microbiol Antimicrob"},{"issue":"9","key":"8803_CR31","doi-asserted-by":"publisher","first-page":"e0222911","DOI":"10.1371\/journal.pone.0222911","volume":"14","author":"D Beyene","year":"2019","unstructured":"Beyene D, Bitew A, Fantew S, Mihret A, Evans M. Multidrug-resistant profile and prevalence of extended spectrum \u03b2-lactamase and carbapenemase production in fermentative Gram-negative bacilli recovered from patients and specimens referred to National Reference Laboratory, Addis Ababa, Ethiopia. PLoS One. 2019;14(9):e0222911.","journal-title":"PLoS One"},{"issue":"11","key":"8803_CR32","doi-asserted-by":"publisher","first-page":"e0277230","DOI":"10.1371\/journal.pone.0277230","volume":"17","author":"Z Haile","year":"2022","unstructured":"Haile Z, Mengist HM, Dilnessa T. Bacterial isolates, their antimicrobial susceptibility pattern, and associated factors of external ocular infections among patients attending eye clinic at Debre Markos Comprehensive Specialized Hospital, Northwest Ethiopia. PLoS One. 2022;17(11):e0277230.","journal-title":"PLoS One"},{"issue":"8","key":"8803_CR33","first-page":"1085","volume":"5","author":"A Aklilu","year":"2018","unstructured":"Aklilu A, Bitew A, Dessie W, Hailu E, Asamene N, Mamuye Y. Prevalence and drug susceptibility pattern of bacterial pathogens from ocular infection in St. Paul\u2019s Hospital Millennium Medical College, Ethiopia. J Bacteriol Mycol. 2018;5(8):1085.","journal-title":"J Bacteriol Mycol."},{"issue":"1","key":"8803_CR34","first-page":"019","volume":"1","author":"T Aweke","year":"2014","unstructured":"Aweke T, Dibaba G, Ashenafi K, Kebede M. Bacterial pathogens of exterior ocular infections and their antibiotic vulnerability pattern in southern Ethiopia. Afr J Immunol Res. 2014;1(1):019\u201325.","journal-title":"Afr J Immunol Res"}],"updated-by":[{"DOI":"10.1186\/s12879-023-08921-6","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2024,1,2]],"date-time":"2024-01-02T00:00:00Z","timestamp":1704153600000}}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-023-08803-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-023-08803-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-023-08803-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,2]],"date-time":"2024-01-02T16:04:34Z","timestamp":1704211474000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-023-08803-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,15]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["8803"],"URL":"https:\/\/doi.org\/10.1186\/s12879-023-08803-x","relation":{"correction":[{"id-type":"doi","id":"10.1186\/s12879-023-08921-6","asserted-by":"object"}]},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,15]]},"assertion":[{"value":"17 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 November 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 November 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 January 2024","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1186\/s12879-023-08921-6","URL":"https:\/\/doi.org\/10.1186\/s12879-023-08921-6","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All methods applied in this work were carried out by following guidelines and regulations. All experimental protocols were performed in line with the prepared standard operating procedures (SOPs) approved by the EPHI. The study was approved by the ethics committee of College of Medicine and Health Sciences, Ambo University. Informed consent was obtained from all subjects and\/or their legal guardian(s) during specimen collection. A letter of permission to use antimicrobial resistance data was written to EPHI from Ambo University College of Medicine and Health Sciences. After obtaining permission from the EPHI, the information recorded in electronic data was utilized for data extraction. Patient records were anonymized before analysis.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"798"}}